109 related articles for article (PubMed ID: 28370155)
1. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
Jansen L; Weberpals J; Kuiper JG; Vissers PAJ; Wolkewitz M; Hoffmeister M; Brenner H
Int J Cancer; 2017 Jul; 141(1):62-71. PubMed ID: 28370155
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
3. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
[TBL] [Abstract][Full Text] [Related]
4. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
5. Beta blocker use and colorectal cancer risk: population-based case-control study.
Jansen L; Below J; Chang-Claude J; Brenner H; Hoffmeister M
Cancer; 2012 Aug; 118(16):3911-9. PubMed ID: 22585669
[TBL] [Abstract][Full Text] [Related]
6. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
7. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
8. Association between perioperative beta blocker use and cancer survival following surgical resection.
Musselman RP; Bennett S; Li W; Mamdani M; Gomes T; van Walraven C; Boushey R; Al-Obeed O; Al-Omran M; Auer RC
Eur J Surg Oncol; 2018 Aug; 44(8):1164-1169. PubMed ID: 29858097
[TBL] [Abstract][Full Text] [Related]
9. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
de Kort S; Simons CC; van den Brandt PA; Goldbohm RA; Arts IC; de Bruine AP; Janssen-Heijnen ML; Sanduleanu S; Masclee AA; Weijenberg MP
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):896-903. PubMed ID: 27097356
[TBL] [Abstract][Full Text] [Related]
11. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
[TBL] [Abstract][Full Text] [Related]
12. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
13. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
[TBL] [Abstract][Full Text] [Related]
14. Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan.
Shao YY; Hsu CH; Yeh KH; Chen HM; Yeh YC; Lai CL; Lin ZZ; Cheng AL; Lai MS
Clin Colorectal Cancer; 2015 Sep; 14(3):177-184.e4. PubMed ID: 25770059
[TBL] [Abstract][Full Text] [Related]
15. Smoking and survival of colorectal cancer patients: population-based study from Germany.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
[TBL] [Abstract][Full Text] [Related]
16. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
18. β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis.
Thenappan T; Roy SS; Duval S; Glassner-Kolmin C; Gomberg-Maitland M
Circ Heart Fail; 2014 Nov; 7(6):903-10. PubMed ID: 25277998
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
[TBL] [Abstract][Full Text] [Related]
20. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
